One-year contraceptive continuation and pregnancy in adolescent girls and women initiating hormonal contraceptives

Obstetrics and Gynecology

Volumn 117, Issue 2, 2011, Pages 363-371

  Raine, Tina R ^a   Foster Rosales, Anne ^a   Upadhyay, Ushma D ^b   Boyer, Cherrie B ^b   Brown, Beth A ^b   Sokoloff, Abby ^b   Harper, Cynthia C ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEDROXYPROGESTERONE ACETATE; ORAL CONTRACEPTIVE AGENT;

ADOLESCENT; ADULT; AGE; ARTICLE; COMPARATIVE STUDY; CONTRACEPTIVE DEVICE; DRUG WITHDRAWAL; FAMILY PLANNING; FEMALE; HORMONAL CONTRACEPTION; HUMAN; NORMAL HUMAN; OUTCOME ASSESSMENT; PREGNANCY RATE; PRIORITY JOURNAL; QUESTIONNAIRE; UNPLANNED PREGNANCY; VAGINA RING;

ADOLESCENT; CONTRACEPTION BEHAVIOR; CONTRACEPTIVE AGENTS, FEMALE; FEMALE; HUMANS; LONGITUDINAL STUDIES; MEDICATION ADHERENCE; MEDROXYPROGESTERONE ACETATE; PREGNANCY; PREGNANCY RATE; YOUNG ADULT;

EID: 79251563148     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0b013e31820563d3     Document Type: Article

References (31)

1. Finer LB, Henshaw SK. Disparities in rates of unintended pregnancy in the United States, 1994 and 2001. Perspect Sex Reprod Health 2006;38:90-6.
2. Ranjit N, Bankole A, Darroch JE, Singh S. Contraceptive failure in the first two years of use: differences across socioeconomic subgroups. Fam Plann Perspect 2001;33:19-27.
3. Frost JJ, Singh S, Finer LB. U.S. women's one-year contraceptive-use patterns, 2004. Perspect Sex Reprod Health 2007;38-55.
4. Glei DA. Measuring contraceptive use patterns among teenage and adult women. Fam Plann Perspect 1999;31:73-80.
5. Rosenberg MJ, Burnhill MS, Waugh MS, Grimes DA, Hillard PJ. Compliance and oral contraceptives: a review. Contraception 1995;52:137-41.
6. Westhoff C, Heartwell S, Edwards S, Zieman M, Cushman L, Robilotto C, et al. Initiation of oral contraception using quick start compared with a conventional start: a randomized controlled trial. Obstet Gynecol 2007;109:1270-6.
7. Sangi-Haghpeykar H, Poindexter AN 3rd, Bateman L, Ditmore JR. Experiences of injectable contraceptive users in an urban setting. Obstet Gynecol 1996;88:227-33.
8. Westfall JM, Main DS, Barnard L. Continuation rates among injectable contraceptive users. Fam Plann Perspect 1996;28:275-7.
9. Polaneczky M, Liblanc M. Long-term depot medroxyprogesterone acetate (Depo-Provera) use in inner-city adolescents. J Adolesc Health 1998;23:81-8.
10. Mosher WD, Martinez GM, Chandra A, Abma JC, Willson SJ. Use of contraception and use of family planning services in the United States: 1982-2002. Adv Data 2004;350:1-36.
11. Trussell J, Vaughan B. Contraceptive failure, method related-discontinuation and resumption of use: Results from the 1995 National Survey of Family Growth. Fam Plann Perspect 1999;31:64-72,93.
12. Archer DF, Bigrigg A, Smallwood GH, Shangold GA, Creasy GW, Fisher AC. Assessment of compliance with a weekly contraceptive patch (Ortho Evra/Evra) among North American women. Fertil Steril 2002;77:S27-31.
13. Dieben TO, Roumen FJ, Apter D. Efficacy, cycle control, and user acceptability of a novel combined contraceptive vaginal ring. Obstet Gynecol 2002;100:585-93.
14. Creinin MD, Meyn LA, Borgatta L, Barnhart K, Jensen J, Burke AE, et al. Multicenter comparison of the contraceptive ring and patch: a randomized controlled trial. Obstet Gynecol 2008;111:267-77.
15. Rubinstein ML, Halpern-Felsher BL, Irwin CE Jr. An evaluation of the use of the transdermal contraceptive patch in adolescents. J Adolesc Health 2004;34:395-401.
16. Harel Z, Riggs S, Vaz R, Flanagan P, Dunn K, Harel D. Adolescents' experience with the combined estrogen and progestin transdermal contraceptive method Ortho Evra. Pediatr Adolesc Gynecol. 2005;18:85-90.
17. Groves RM, Benson G, Mosher WD, Rosenbaum J, Granda P, Axinn W, et al. Plan and operation of cycle 6 of the National Survey of Family Growth. Vital Health Stat 2005;1:1-86.
18. California health Interview Surveys. Available at: Retrieved January 6, 2010.
19. Behavioral Risk Factor Surveillance system questionnaires. Available at: Retrieved January 6, 2010.
20. Novák A, de la Loge C, Abetz L. Development and validation of an acceptability and satisfaction questionnaire for a contraceptive vaginal ring, NuvaRing. Pharmacoeconomics 2004;22:245-56.
21. Ajzen I, Fishbein M. Understanding attitudes and predicting social behavior. Englewood Cliffs (NJ): Prentice-Hall; 1980.
22. Raine TR, Gard J, Boyer CB, Haider S, Brown BA, Ramirez Hernandez FA, et al. Contraceptive decision-making in sexual relationships: young men's experiences, attitudes, and values. Culture Health Sex 2010;12:373-86.
23. Raine TR, Epstein LB, Harper CC, Brown BA, Boyer CB. Attitudes toward the vaginal ring and transdermal patch among adolescents and young women. J Adol Health 2009;45:262-7.
24. Collett D. Modelling survival data in medical research. London (UK): Chapman & Hall; 1994.
25. Cox DR. Regression models and life tables. R Stat Soc 1972;34:187-220.
26. Speroff L, Darney PD, editors. A clinical guide for contraception. 4th ed. Philadelphia (PA): Lippincott Williams & Wilkins; 2005.
27. Moore PJ, Adler NE, Kegeles SM. Adolescents and the contraceptive pill: the impact of beliefs on intentions and use. Obstet Gynecol 1996;88:48S-56S.
28. Kirby D. The impact of programs to increase contraceptive use among adult women: a review of experimental and quasi-experimental studies. Perspect Sex Reprod Health 2008;40:34-41.
29. Westhoff C, Heartwell S, Edwards S, Zieman M, Stuart G, Cwiak C, et al. Oral contraceptive discontinuation: do side-effects matter? Am J Obstet Gynecol 2007;196:412.e1-7.
30. FamilyPACT web site. Available at: Retrieved January 6, 2010.
31. Kost K, Singh S, Vaughan B, Trussell J, Bankole A. Estimates of contraceptive failure from the 2002 National Survey of Family Growth. Contraception 2008;77:10-21.